"Neuromyelitis Optica" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A syndrome characterized by acute OPTIC NEURITIS; MYELITIS, TRANSVERSE; demyelinating and/or necrotizing lesions in the OPTIC NERVES and SPINAL CORD; and presence of specific autoantibodies to AQUAPORIN 4.
Descriptor ID |
D009471
|
MeSH Number(s) |
C10.114.375.600.500 C10.114.375.800 C10.292.700.550.500 C10.314.350.600.500 C10.314.350.800 C11.640.576.695 C20.111.258.250.550.500 C20.111.258.250.775
|
Concept/Terms |
Neuromyelitis Optica- Neuromyelitis Optica
- NMO Spectrum Disorder
- NMO Spectrum Disorders
- Neuromyelitis Optica (NMO) Spectrum Disorder
- Neuromyelitis Optica Spectrum Disorders
- Neuromyelitis Optica (NMO) Spectrum Disorders
- Devic Neuromyelitis Optica
- Devic Neuromyelitis Opticas
- Neuromyelitis Optica, Devic
- Neuromyelitis Opticas, Devic
- Devic Disease
- Disease, Devic
- Devic Syndrome
- Syndrome, Devic
- Devic's Syndrome
- Devics Syndrome
- Syndrome, Devic's
- Devic's Neuromyelitis Optica
- Devics Neuromyelitis Optica
- Neuromyelitis Optica, Devic's
- Neuromyelitis Optica Spectrum Disorder
- Devic's Disease
- Devics Disease
- Disease, Devic's
|
Below are MeSH descriptors whose meaning is more general than "Neuromyelitis Optica".
Below are MeSH descriptors whose meaning is more specific than "Neuromyelitis Optica".
This graph shows the total number of publications written about "Neuromyelitis Optica" by people in this website by year, and whether "Neuromyelitis Optica" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2012 | 2 | 0 | 2 |
2017 | 10 | 0 | 10 |
2018 | 12 | 0 | 12 |
2019 | 6 | 0 | 6 |
2020 | 6 | 0 | 6 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Neuromyelitis Optica" by people in Profiles.
-
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders. Neurol Neuroimmunol Neuroinflamm. 2021 11; 8(6).
-
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
-
Association of CNS demyelination and COVID-19 infection: an updated systematic review. J Neurol. 2022 Feb; 269(2):541-576.
-
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2022 01; 93(1):24-31.
-
Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases. Mult Scler Relat Disord. 2021 Oct; 55:103189.
-
Oral administration of methylprednisolone powder for intravenous injection dissolved in water to treat MS and NMOSD relapses during COVID-19 pandemic in a real-world setting. Mult Scler Relat Disord. 2021 Sep; 54:103148.
-
Post-COVID Neuromyelitis Optica Spectrum Disorder. J Coll Physicians Surg Pak. 2021 07; 31(7):138-140.
-
Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurol Sci. 2021 Sep; 42(9):3537-3539.
-
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia. Mult Scler Relat Disord. 2021 Sep; 54:103104.
-
COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica. J Neurol. 2021 Dec; 268(12):4479-4482.